A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups.

[1]  R. Smyth,et al.  Vaccines for preventing influenza in people with cystic fibrosis. , 2014, The Cochrane database of systematic reviews.

[2]  L. Kremer,et al.  Influenza vaccination in children being treated with chemotherapy for cancer. , 2013, The Cochrane database of systematic reviews.

[3]  B. Rowe,et al.  Vaccines for preventing influenza in people with asthma. , 2013, The Cochrane database of systematic reviews.

[4]  T. Jefferson,et al.  Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.

[5]  Cécile Viboud,et al.  Quantitative review of antibody response to inactivated seasonal influenza vaccines , 2011, Influenza and other respiratory viruses.

[6]  P. Bossuyt,et al.  Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations , 2011, Allergy.

[7]  A. Monto,et al.  Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. , 2011, The Journal of infectious diseases.

[8]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[9]  S. Ha,et al.  Vaccines for prophylaxis of viral infections in patients with hematological malignancies. , 2011, The Cochrane database of systematic reviews.

[10]  H. Ehrlich,et al.  Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial , 2011, The Lancet.

[11]  W. Wongcharoen,et al.  Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. , 2011, European heart journal.

[12]  T. Jefferson,et al.  Influenza vaccination for healthcare workers who work with the elderly: systematic review. , 2010, Vaccine.

[13]  T. Vesikari,et al.  Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  B. Fireman,et al.  Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. , 2010, Vaccine.

[15]  A. Monto.  Seasonal influenza vaccinations: specialized products for different target groups. , 2010, Vaccine.

[16]  R. Belshe,et al.  The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination , 2010, The Pediatric infectious disease journal.

[17]  U. Yılmaz,et al.  Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease. , 2010, The new microbiologica.

[18]  John J Treanor,et al.  Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons , 2010, BMC infectious diseases.

[19]  D. Earn,et al.  Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. , 2010, JAMA.

[20]  Janelle Y Lee,et al.  Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. , 2010, The Journal of infectious diseases.

[21]  A. Monto,et al.  Comparative efficacy of inactivated and live attenuated influenza vaccines. , 2009, The New England journal of medicine.

[22]  Y. Hirota,et al.  Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan--with special reference to minimizing outcome misclassification. , 2009, Vaccine.

[23]  Mark A. Miller,et al.  Influenza vaccination and mortality benefits: new insights, new opportunities. , 2009, Vaccine.

[24]  Jeremy Grimshaw,et al.  AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. , 2009, Journal of clinical epidemiology.

[25]  S. Esposito,et al.  Efficacy of Injectable Trivalent Virosomal-Adjuvanted Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Children With Recurrent Complicated or Noncomplicated Acute Otitis Media , 2009, The Pediatric infectious disease journal.

[26]  Bruce Fireman,et al.  Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias , 2009, American journal of epidemiology.

[27]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[28]  T. Vesikari,et al.  Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant , 2009, The Pediatric infectious disease journal.

[29]  Min Liu,et al.  [Meta analysis on the effectiveness of inactivated influenza vaccine]. , 2009, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[30]  S. Arifeen,et al.  Effectiveness of maternal influenza immunization in mothers and infants. , 2008, The New England journal of medicine.

[31]  G. Rimmelzwaan,et al.  Correlates of protection: novel generations of influenza vaccines. , 2008, Vaccine.

[32]  R. Couch.  Seasonal inactivated influenza virus vaccines. , 2008, Vaccine.

[33]  K. Nichol.  Efficacy and effectiveness of influenza vaccination. , 2008, Vaccine.

[34]  T. Marrie,et al.  Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? , 2008, American journal of respiratory and critical care medicine.

[35]  J. Nelson,et al.  Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study , 2008, The Lancet.

[36]  A. Monto,et al.  Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. , 2008, The Journal of infectious diseases.

[37]  M. Levi,et al.  Influenza vaccines for preventing coronary heart disease. , 2008, The Cochrane database of systematic reviews.

[38]  A. Hoes,et al.  Effects of Influenza Plus Pneumococcal Conjugate Vaccination Versus Influenza Vaccination Alone in Preventing Respiratory Tract Infections in Children: A Randomized, Double-Blind, Placebo-Controlled Trial , 2008, The Journal of Pediatrics.

[39]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[40]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[41]  Mohd Hasni Jaafar,et al.  Effectiveness of influenza vaccine in preventing influenza-like illness among Faculty of Dentistry staff and students in Universiti Kebangsaan Malaysia , 2008, Healthcare Infection.

[42]  J. Brownstein,et al.  Efficacy of influenza vaccination in HIV‐positive patients: a systematic review and meta‐analysis , 2008, HIV medicine.

[43]  K. Nichol,et al.  Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.

[44]  Cecile Viboud,et al.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.

[45]  Christina C. Chang,et al.  Influenza vaccine for children and adults with bronchiectasis. , 2007, The Cochrane database of systematic reviews.

[46]  H. Cheong,et al.  Clinical impact of influenza immunization in patients with liver cirrhosis. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[47]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[48]  A. Monto,et al.  Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. , 2006, The New England journal of medicine.

[49]  Michiels Barbara,et al.  The effect of giving influenza vaccination to general practitioners: a controlled trial [NCT00221676] , 2006 .

[50]  A. Hoes,et al.  Benefits of influenza vaccine in US elderly--appreciating issues of confounding bias and precision. , 2006, International journal of epidemiology.

[51]  J. Nelson,et al.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors. , 2006, International journal of epidemiology.

[52]  Lone Simonsen,et al.  Commentary: benefits of influenza vaccine in US elderly--new studies raise questions. , 2006, International journal of epidemiology.

[53]  R. Wood‐Baker,et al.  Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[54]  J C van der Wouden,et al.  Preventing influenza: an overview of systematic reviews. , 2005, Respiratory medicine.

[55]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[56]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[57]  C. V. Hoecke,et al.  Ten Years of Experience with the Trivalent Split-Influenza Vaccine, Fluarix™ , 2002 .

[58]  P A West,et al.  Economic evaluation of strategies for the control and management of influenza in Europe. , 2002, Vaccine.

[59]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[60]  P. Scuffham,et al.  Cost Effectiveness of Influenza Vaccination in Older Adults , 2012, PharmacoEconomics.

[61]  S. Madhi,et al.  Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  J. Kaldor,et al.  Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[63]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[64]  Malbea A Lapete,et al.  Morbidity and Mortality Weekly Report Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Epidemiology Program Office Early Release 1 Prevention and Control of Influenza Recommendations of the Advis , 2022 .

[65]  T. Jefferson,et al.  Vaccines for preventing influenza in people with asthma. , 2000, The Cochrane database of systematic reviews.